Incidence and prevalence of idiopathic pulmonary fibrosis.
about
The effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluationRespiratory diseases caused by coal mine dustOccupational risks for idiopathic pulmonary fibrosis mortality in the United StatesCase report: lung disease in World Trade Center responders exposed to dust and smoke: carbon nanotubes found in the lungs of World Trade Center patients and dust samplesPleural mesothelial cell differentiation and invasion in fibrogenic lung injuryNon-steroid agents for idiopathic pulmonary fibrosisCombined pulmonary fibrosis and emphysema syndrome: a reviewRegulation of transforming growth factor-β1-driven lung fibrosis by galectin-3Genetic interstitial lung diseaseAsbestosis and environmental causes of usual interstitial pneumoniaRedox mechanisms in age-related lung fibrosisCardiac manifestations of idiopathic pulmonary fibrosisNew perspectives on management of idiopathic pulmonary fibrosisPharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future PerspectivesBreakdown of Epithelial Barrier Integrity and Overdrive Activation of Alveolar Epithelial Cells in the Pathogenesis of Acute Respiratory Distress Syndrome and Lung FibrosisManaging comorbidities in idiopathic pulmonary fibrosisPirfenidone for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-AnalysisThe short and long telomere syndromes: paired paradigms for molecular medicineTelomerase and idiopathic pulmonary fibrosisDiverse functions of matrix metalloproteinases during fibrosisCell-based therapy in lung regenerative medicineMatrix biology of idiopathic pulmonary fibrosis: a workshop report of the national heart, lung, and blood instituteEpigenomics of idiopathic pulmonary fibrosisAir pollution exposure: a novel environmental risk factor for interstitial lung disease?Cellular mechanisms of tissue fibrosis. 7. New insights into the cellular mechanisms of pulmonary fibrosisAgeing and the epidemiology of multimorbidityPromotion of lung health: NHLBI Workshop on the Primary Prevention of Chronic Lung DiseasesMolecular biomarkers in idiopathic pulmonary fibrosisEvolving genomic approaches to idiopathic pulmonary fibrosis: moving beyond genesSmoking-related interstitial lung diseaseDiagnosis of idiopathic pulmonary fibrosis: Current issues.Advanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug DeliveryViruses in Idiopathic Pulmonary Fibrosis. Etiology and ExacerbationAn official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and managementBUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosisNuclear Factor-Erythroid-2-Related Factor 2 in Aging and Lung FibrosisSecreted Phosphoprotein 1 and Sex-Specific Differences in Silica-Induced Pulmonary Fibrosis in Miceγδ T cells attenuate bleomycin-induced fibrosis through the production of CXCL10Time-dependent and somatically acquired mitochondrial DNA mutagenesis and respiratory chain dysfunction in a scleroderma model of lung fibrosisPulmonary fibrosis: pathogenesis, etiology and regulation
P2860
Q21195756-BC92A9F4-73D6-491C-A90E-B68A3F6908F7Q23909500-235F4E1D-1942-4399-ABCE-B20B39FFAE70Q23913132-28BE15AE-98D2-42CD-A6A7-319547000708Q23917545-036F8D00-7775-4184-9F59-ADBAFC04A5D7Q24169756-7232D2D2-9777-42EB-8E85-D1D40553FBF4Q24235478-DDFE6BEA-883B-4D9B-B69C-63420B9FE281Q24614740-871724A0-05F3-4569-9618-1C114F029591Q24624887-B581BB86-8D60-425E-895F-794C7B2D3E64Q24626239-DE395304-FBA4-42DA-94AA-133F15081ABEQ26159097-BFC501F0-00C9-45ED-91CE-D0A82955BEACQ26743421-49A1CA4E-D9A8-4B80-9E59-81F879695C86Q26748176-965B9828-1B04-48A5-9F85-03E545C80539Q26765586-452184D8-742E-439C-AEEE-90C8D13DFF85Q26771309-B9674D71-5B65-4820-B749-189924539976Q26777474-0B8B6B19-395A-42C5-8204-CE0D58F33CCFQ26785617-6C210256-2A90-4393-B5A8-188178E8FD40Q26797272-B9EA2B77-618E-464F-8082-C9D7723108FEQ26800388-35DC8D8D-6714-430F-BB1D-3F22D39EB2B3Q26825080-310B379F-5B12-49F7-87B1-331EEDB8F5B8Q26825368-97220BE5-2A83-400A-B8F4-4F4E746C9C9AQ26852285-76F73224-F1B5-43CE-831F-0848F8545822Q26852563-F137ABFE-1E2D-42E4-B177-E6DCA888A261Q26853673-A16A6761-31C6-4533-B686-5A7357A8D7AAQ26991669-2A28732C-2082-4B7C-924D-745B65145ACAQ27003892-FACBAC60-3F16-4420-A6AC-80C540C24613Q27012096-8103A655-C4A1-4BB3-8DE9-5F0AC04BCB81Q27023983-DD5BEDF8-78BB-4142-96C8-D248E4130F07Q27025340-74E8512E-CDB5-44B9-972E-2489034576C0Q27025625-091F9636-EFF4-45DC-806A-D61BD81DFFCCQ27027779-3610EC2F-736A-44FE-9555-AE49A35B0BE1Q27687737-E60DD275-77D4-44D8-A1CE-FD82AA0802FEQ28076132-06D1DE83-1D83-4BA2-8D3A-2AC4EB42D456Q28081676-8072F32C-C42D-44B7-93C6-85F3D862840EQ28308246-4810C518-BA34-4690-BB30-E5FCAFF6B9D8Q28308276-37B307B5-9872-44B8-89A1-B29C70370328Q28383171-A02002DA-2579-4367-A66F-61F6BF1A8F25Q28386089-471AEBBE-054B-4636-8F81-DBDEC4CA6289Q28387454-48D62EA8-799A-4682-8359-39746C57564BQ28388130-D72430B6-518B-4735-AE8E-D20ECAEDD1D2Q28388425-A19D9C4A-2865-435C-A6DF-479D2322E8F3
P2860
Incidence and prevalence of idiopathic pulmonary fibrosis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Incidence and prevalence of idiopathic pulmonary fibrosis.
@ast
Incidence and prevalence of idiopathic pulmonary fibrosis.
@en
type
label
Incidence and prevalence of idiopathic pulmonary fibrosis.
@ast
Incidence and prevalence of idiopathic pulmonary fibrosis.
@en
prefLabel
Incidence and prevalence of idiopathic pulmonary fibrosis.
@ast
Incidence and prevalence of idiopathic pulmonary fibrosis.
@en
P2093
P1476
Incidence and prevalence of idiopathic pulmonary fibrosis.
@en
P2093
Derek Weycker
Ganesh Raghu
Gerry Oster
John Edelsberg
Williamson Z Bradford
P304
P356
10.1164/RCCM.200602-163OC
P407
P577
2006-06-29T00:00:00Z